Form 13-F position report

EIKON THERAPEUTICS INC

Reported by Foresite Capital Management V LLC

EIKN CUSIP 282564103 Manager CIK 0001792206

Reported 1,318,983 shares, unchanged from the prior quarter.

Reported value -38.4%; share count 0.0% vs. the prior quarter.

Unchanged
% of reported 13F value 3.67% This manager · Q3 2026
Shares 1,318,983 Quarter-end amount reported
Reported value $10,604,623 Fair value at quarter end
Consecutive quarters held 3 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2026-03-31 13954840
2026-06-30 17212728
2026-09-30 10604623

Quarterly position history

How this manager's reported quarter-end position changed over time.

3 quarters
Quarterly reported position history for EIKON THERAPEUTICS INC held by Foresite Capital Management V LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Unchanged 1,318,983 0 (0.0%) 3.67% $10,604,623 2026-11-16
Q2 2026 Unchanged 1,318,983 0 (0.0%) 4.75% $17,212,728 2026-08-14
Q1 2026 New 1,318,983 +1,318,983 (0.0%) 5.15% $13,954,840 2026-05-15

Who else reported the position

107 managers reported EIKON THERAPEUTICS INC for Q3 2026.

Managers reporting EIKON THERAPEUTICS INC in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
FMR LLC Added 5,520,152 +526,246 < 0.01% $44,382,022 3 qtrs
BlackRock Inc Added 4,869,276 +587,851 < 0.01% $39,148,980 3 qtrs
Foresite Capital Management IV LLC Unchanged 1,943,682 0 6.2% $15,627,203 3 qtrs
Merck & Co Inc Unchanged 1,666,666 0 1.63% $13,399,995 3 qtrs
T Rowe Price Investment Management Inc Added 1,637,441 +42,167 < 0.01% $13,166,000 3 qtrs
Foresite Capital Management V LLC This report Unchanged 1,318,983 0 3.67% $10,604,623 3 qtrs
Capital World Investors Unchanged 1,175,944 0 < 0.01% $9,454,590 3 qtrs
PRICE T ROWE ASSOCIATES INC MD Added 1,110,649 +105,614 < 0.01% $8,931,000 3 qtrs
ALLIANCEBERNSTEIN L P Added 1,052,041 +410,153 < 0.01% $8,458,410 3 qtrs
VANGUARD CAPITAL MANAGEMENT LLC Added 1,015,513 +92,806 < 0.01% $8,164,725 3 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 16, 2026
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
1,318,983
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.